Skip to content
Quebec News Tribune – Lifestyle
Author:
GT Medical Technologies
Novel Radiation Strategy Redefines a New Treatment Paradigm for Glioblastoma
August 18, 2026
GT Medical Technologies Completes Oversubscribed $100 Million Series E Equity Financing to Advance Commercial Treatment for Patients with Operable Brain Tumors
June 9, 2026
ROADS Phase 3 Clinical Trial Data Presented at ASCO26 Show GammaTile® Provides Superior Tumor Control Leading to Patients Living Longer Without Recurrence Compared to Standard of Care in Newly Diagnosed Operable Brain Metastases
May 30, 2026